Angiogenesis in Acute and Chronic Leukemias
- 1 January 2001
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 42 (5) , 847-853
- https://doi.org/10.3109/10428190109097703
Abstract
Angiogenesis plays a key role in the growth of solid tumors. More recently, accumulating evidence has linked angiogenesis to the pathophysiology of leukemias. Different investigators have shown evidence of increased angiogenesis in the bone marrows of patients with acute and chronic leukemias. Elevated levels of angiogenic factors have also been reported in leukemic patients. A potential role for VEGF as an autocrine growth factor in AML has been suggested. Studies on the role of angiogenesis and VEGF as prognostic factors in leukemia require confirmation. The role of angiogenesis inhibitors in the treatment of leukemia is currently under investigation.Keywords
This publication has 16 references indexed in Scilit:
- Vascular-specific growth factors and blood vessel formationNature, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migrationJournal of Clinical Investigation, 2000
- Increased angiogenesis in the bone marrow of patients with acute myeloid leukemiaBlood, 2000
- Evidence of increased angiogenesis in patients with acute myeloid leukemiaBlood, 2000
- Angiogenesis: a Dynamic Balance of Stimulators and InhibitorsThrombosis and Haemostasis, 1997
- Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor PrognosisJNCI Journal of the National Cancer Institute, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Bone marrow stromal cell changes in haematological malignancies.Journal of Clinical Pathology, 1990